The Roskamp Institute scientists have a long history of research examining the causes and potential cures for neurological disorders, particularly dementias such as Alzheimer’s Disease. During several decades of research it has become abundantly clear that one of the...

Very unfortunately, today Biogen announced that it’s late-stage clinical trials for Alzheimer’s Disease using the drug Aducanumab have failed. Aducanumab was designed to target one of the main pathologies in Alzheimer’s Disease, namely, amyloid accumulation....

We'd like to say thank you to all the veterans and supporters that showed up for our open house this year. We were absolutely blown away by the number of people engaging with our scientists and learning about our research projects. We hope you enjoyed talks on PTSD,...

The Roskamp Institute is pleased to announce that its second annual seminar, Grey Matters—A Symposium on Alzheimer’s Disease Research, is nearly sold out. “We are thrilled with the outpouring of support for our Grey Matters event. The level of interest speaks to the...

A research project at The Roskamp Institute has demonstrated for the first time that mild Traumatic Brain Injury (mTBI) or concussion can precipitate a lifelong degenerative process in the brain. The findings of this study, led by Dr. Fiona Crawford and conducted by...

This year’s Veterans Day event was a smashing success and we’d like to thank everyone who came out to visit and take part in making history.

The Roskamp Institute is pleased to announce that the first annual Grey Matters Symposium on Alzheimer’s Disease Research has sold out.